Pennant Group Inc

Pennant Group Inc (PNTG) Stock Analysis

$40.820

+0.682 (+1.67%)At close

Loading chart…
High
40.960
Open
40.030
VWAP
40.60
Volume
153.46K
Mkt Cap
682.34M
Low
40.030
Amount
6.23M
EV/EBITDA, TTM
21.25

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming, Tennessee, Georgia and Alabama. Each of these businesses is operated by a separate, independent operating subsidiary. Its segments include home health and hospice services, and senior living services. Its home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. Its senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples.

AI analysis of Pennant Group Inc (PNTG)

Buy

Pennant Group Inc is a good buy right now due to its current price of $39.73, which is below the analyst price target range of $40 to $48, indicating potential upside. The company has shown strong financial performance with a year-to-date change of +42.76% and a one-year change of +65.61%. Additionally, the forward P/E ratio is at 25.45, suggesting growth expectations are already priced in, but the recent acquisition of Copper Canyon Memory Care may enhance future earnings. The main risk is the CEO's recent stock sale, where he sold 3,159 shares at $41.56, which could indicate some short-term caution among insiders.

Valuation Metrics

The current forward P/E ratio for Pennant Group Inc (PNTG) is 25.45, compared to its 5-year average forward P/E of 22.68.

Forward P/E

Fair
5Y Average P/E
22.68
Current P/E
25.45
Overvalued
28.57
Undervalued
16.79

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
17.57
Current EV/EBITDA
21.25
Overvalued
21.40
Undervalued
13.73

Forward P/S

Fair
5Y Average P/S
0.94
Current P/S
1.11
Overvalued
1.19
Undervalued
0.70

Alphio AI Price Scenarios for PNTG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PNTG

$42.17

Scenario price

B

Base

Base · 50%PNTG

$35.43

Scenario price

B

Bear

Bear · 25%PNTG

$29.17

Scenario price

Whales holding PNTG

T

Turtle Creek Asset Management Inc.

+ HoldingPNTG

-6.73%

3M Return

PNTG FAQ — answered by Alphio AI

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming, Tennessee, Georgia and Alabama. Each of these businesses is operated by a separate, independent operating subsidiary. Its segments include home health and hospice services, and senior living services. Its home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. Its senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Pennant Group Inc is a good buy right now due to its current price of $39.73, which is below the analyst price target range of $40 to $48, indicating potential upside. The company has shown strong financial performance with a year-to-date change of +42.76% and a one-year change of +65.61%. Additionally, the forward P/E ratio is at 25.45, suggesting growth expectations are already priced in, but the recent acquisition of Copper Canyon Memory Care may enhance future earnings. The main risk is the CEO's recent stock sale, where he sold 3,159 shares at $41.56, which could indicate some short-term caution among insiders.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading